APA (7th ed.) Citation

Noor, N. M., Zheng, H., Robertson, D. S., Savage, J., Yap, C., Jorgensen, A. L., . . . Group, o. b. o. t. M. T. M. R. P. P. M. W. Interpreting results from biomarker-guided clinical trials: Avoiding “negative” or “failed” terminology. BMC.

Chicago Style (17th ed.) Citation

Noor, Nurulamin M., Haiyan Zheng, David S. Robertson, Joshua Savage, Christina Yap, Andrea L. Jorgensen, James M. S. Wason, and on behalf of the MRC-NIHR Trial Methodology Research Partnership Precision Medicine Working Group. Interpreting Results from Biomarker-guided Clinical Trials: Avoiding “negative” or “failed” Terminology. BMC.

MLA (9th ed.) Citation

Noor, Nurulamin M., et al. Interpreting Results from Biomarker-guided Clinical Trials: Avoiding “negative” or “failed” Terminology. BMC.